Article Details

BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors

Retrieved on: 2018-05-08 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors. View article details on hiswai:

Excerpt

<div>New investors, Sectoral Asset Management and INKEF Capital, joined existing investors <b>Sofinnova Ventures</b>, Ysios Capital, HealthCap, Tekla Capital ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up